NCT07178002View on ClinicalTrials.gov

OM 85 to Prevent Respiratory Infections in Older At Risk Patients

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

April 30, 2026

Conditions
Respiratory Tract Infections (RTI)
Interventions
DRUG

Bacterial Lysate

Administration p.o. for 10 days per month for 3 months, two consecutive cycles.

DRUG

Placebo

Matching placebo

Trial Locations (1)

00128

Fondazione Policlinico Universitario Campus Bio Medico, Roma

Sponsors

Collaborators (1)

OM Pharma SA
All Listed Sponsors
collaborator

OM Pharma SA

INDUSTRY

lead

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER

NCT07178002 - OM 85 to Prevent Respiratory Infections in Older At Risk Patients | Biotech Hunter | Biotech Hunter